Cargando…
Towards a novel peptide vaccine for Middle East respiratory syndrome coronavirus and its possible use against pandemic COVID-19
Middle East respiratory syndrome coronavirus (MERS-CoV) is an emerging health concern due to its high mortality rate of 35%. At present, no vaccine is available to protect against MERS-CoV infections. Therefore, an in silico search for potential antigenic epitopes in the non-redundant proteome of ME...
Autores principales: | Khan, Salman, Shaker, Bilal, Ahmad, Sajjad, Abbasi, Sumra Wajid, Arshad, Muhammad, Haleem, Abdul, Ismail, Saba, Zaib, Anita, Sajjad, Wasim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644433/ https://www.ncbi.nlm.nih.gov/pubmed/33173250 http://dx.doi.org/10.1016/j.molliq.2020.114706 |
Ejemplares similares
-
Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2
por: Ahmad, Sajjad, et al.
Publicado: (2021) -
A computational study to disclose potential drugs and vaccine ensemble for COVID-19 conundrum
por: Ahmad, Sajjad, et al.
Publicado: (2021) -
Structure-Based Virtual Screening Identifies Multiple Stable Binding Sites at the RecA Domains of SARS-CoV-2 Helicase Enzyme
por: Ahmad, Sajjad, et al.
Publicado: (2021) -
Design of a Multi-Epitopes Vaccine against Hantaviruses: An Immunoinformatics and Molecular Modelling Approach
por: Ismail, Saba, et al.
Publicado: (2022) -
Immuno-Informatics Analysis of Pakistan-Based HCV Subtype-3a for Chimeric Polypeptide Vaccine Design
por: Ahmad, Sajjad, et al.
Publicado: (2021)